Chengdu huasun technology group Inc. , LTD. (SHE:000790)
4.210
-0.210 (-4.75%)
May 21, 2026, 3:04 PM CST
SHE:000790 Revenue
Chengdu huasun technology group Inc. , LTD. had revenue of 109.28M CNY in the quarter ending March 31, 2026, a decrease of -13.90%. This brings the company's revenue in the last twelve months to 527.86M, down -34.96% year-over-year. In the year 2025, Chengdu huasun technology group Inc. , LTD. had annual revenue of 545.50M, down -36.86%.
Revenue (ttm)
527.86M
Revenue Growth
-34.96%
P/S Ratio
4.97
Revenue / Employee
726.08K
Employees
727
Market Cap
2.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 545.50M | -318.48M | -36.86% |
| Dec 31, 2024 | 863.98M | -139.40M | -13.89% |
| Dec 31, 2023 | 1.00B | 130.27M | 14.92% |
| Jan 1, 2023 | 873.10M | -81.58M | -8.55% |
| Jan 1, 2022 | 954.69M | 195.38M | 25.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 3.86B |
| Enwei Pharmaceutical | 879.60M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 843.87M |
| Zhejiang Shengda Bio-Pharm | 830.53M |
| Jiangxi Synergy Pharmaceutical | 826.15M |
| Hainan Huluwa Pharmaceutical Group | 710.14M |
| Lionco Pharmaceutical Group | 358.90M |
| Guhan Pharmaceutical Group | 344.12M |